Rich With $20 Million And 15 Preclinical Candidates, Moderna Therapeutics, Inc. Spins Out MRNA Cancer Drugs Into New Company
So much money has flowed into Moderna Therapeutics, it was only a matter of time before the company started spending real dough.
Cambridge, MA-based Moderna, which is developing a new class of messenger RNA molecules as therapies, says it’s investing $20 million to spin out a new company called Onkaido Therapeutics. The new shop will begin life with 15 different cancer drug candidates that had been in preclinical testing at Moderna.
Help employers find you! Check out all the jobs and post your resume.